Our Portfolio Takes a Beating but Still Keeps Ticking
Like most biotech and tech stocks, our portfolio has taken it on the chin since early March, and the punishment may not be over. Nonetheless, our stocks have held their ground near or above the price at which they were recommended. If we take the last six stocks recommended and assume you had purchased $10,000 of each of them, your $60,000 investment would be worth $63,000 as of the close of business last Friday. Nothing to write home about there, but 5% return overall on a one-six-month tech portfolio after a meltdown isn’t bad.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.